Literature DB >> 21292871

Plasmodium vivax vaccine research: insights from Colombian studies.

Falgunee K Parekh, Vasee S Moorthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21292871      PMCID： PMC3032483          DOI： 10.4269/ajtmh.2011.09-0781

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  16 in total

Review 1.  Mapping the global extent of malaria in 2005.

Authors:  Carlos A Guerra; Robert W Snow; Simon I Hay
Journal:  Trends Parasitol       Date:  2006-06-23

Review 2.  An update on the search for a Plasmodium vivax vaccine.

Authors:  Sócrates Herrera; Giampietro Corradin; Myriam Arévalo-Herrera
Journal:  Trends Parasitol       Date:  2007-01-29

3.  Plasmodium vivax malaria in the Republic of Korea during 2004-2005: changing patterns of infection.

Authors:  Joon-Sup Yeom; Tong-Soo Kim; Sejoong Oh; Jai-Bong Sim; Jae-Sang Barn; Hye-Jung Kim; Young-A Kim; Sun-Young Ahn; Mee-Young Shin; Jie-Ae Yoo; Jae-Won Park
Journal:  Am J Trop Med Hyg       Date:  2007-05       Impact factor: 2.345

4.  Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit.

Authors:  Augusto Valderrama-Aguirre; Gustavo Quintero; Andrés Gómez; Alejandro Castellanos; Yobana Pérez; Fabián Méndez; Myriam Arévalo-Herrera; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2005-11       Impact factor: 2.345

5.  Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine.

Authors:  Sócrates Herrera; Anilza Bonelo; Blanca Liliana Perlaza; Olga Lucía Fernández; Leonardo Victoria; Ana Milena Lenis; Liliana Soto; Hugo Hurtado; Lina María Acuña; Juan Diego Vélez; Ricardo Palacios; Mario Chen-Mok; Giampietro Corradin; Myriam Arévalo-Herrera
Journal:  Am J Trop Med Hyg       Date:  2005-11       Impact factor: 2.345

Review 6.  The neglected burden of Plasmodium vivax malaria.

Authors:  K Mendis; B J Sina; P Marchesini; R Carter
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

Review 7.  Cerebral malaria owing to Plasmodium vivax: case report.

Authors:  Metehan Ozen; Serdal Gungor; Metin Atambay; Nilgün Daldal
Journal:  Ann Trop Paediatr       Date:  2006-06

8.  Plasmodium vivax malaria.

Authors:  Dhanpat K Kochar; Vishal Saxena; Narvachan Singh; Sanjay K Kochar; S Vijay Kumar; Ashis Das
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

9.  Malaria reemergence in the Peruvian Amazon region.

Authors:  J Aramburú Guarda; C Ramal Asayag; R Witzig
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

10.  Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.

Authors:  Emiliana Tjitra; Nicholas M Anstey; Paulus Sugiarto; Noah Warikar; Enny Kenangalem; Muhammad Karyana; Daniel A Lampah; Ric N Price
Journal:  PLoS Med       Date:  2008-06-17       Impact factor: 11.069
View more
  3 in total

1.  Accessible mutational trajectories for the evolution of pyrimethamine resistance in the malaria parasite Plasmodium vivax.

Authors:  Pan-Pan Jiang; Russell B Corbett-Detig; Daniel L Hartl; Elena R Lozovsky
Journal:  J Mol Evol       Date:  2013-09-27       Impact factor: 2.395

Review 2.  Immunization in travel medicine.

Authors:  Suzanne Moore Shepherd; William Hudson Shoff
Journal:  Prim Care       Date:  2011-12       Impact factor: 2.907

Review 3.  The Search of a Malaria Vaccine: The Time for Modified Immuno-Potentiating Probes.

Authors:  José Manuel Lozano; Zully Rodríguez Parra; Salvador Hernández-Martínez; Maria Fernanda Yasnot-Acosta; Angela Patricia Rojas; Luz Stella Marín-Waldo; Juan Edilberto Rincón
Journal:  Vaccines (Basel)       Date:  2021-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.